Akoya Biosciences Inc (AKYA)
3.75
-0.07
(-1.83%)
USD |
NASDAQ |
Apr 26, 11:20
Akoya Biosciences Shareholders Equity (Quarterly): 53.77M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 53.77M |
| September 30, 2023 | 61.97M |
| June 30, 2023 | 71.90M |
| March 31, 2023 | 42.12M |
| December 31, 2022 | 58.58M |
| September 30, 2022 | 75.09M |
| June 30, 2022 | 90.85M |
| Date | Value |
|---|---|
| March 31, 2022 | 106.55M |
| December 31, 2021 | 121.35M |
| September 30, 2021 | 137.39M |
| June 30, 2021 | 147.82M |
| March 31, 2021 | -60.00M |
| December 31, 2020 | -51.03M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-60.00M
Minimum
Mar 2021
147.82M
Maximum
Jun 2021
65.88M
Average
71.90M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Bruker Corp | 1.377B |
| Azenta Inc | 2.444B |
| Harvard Bioscience Inc | 73.07M |
| Bionano Genomics Inc | 96.16M |
| Singular Genomics Systems Inc | 179.01M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.37M |
| Total Liabilities (Quarterly) | 126.60M |
| Debt to Equity Ratio | 1.400 |
| Current Ratio | 3.446 |
| Net Debt Paydown Yield | -1.88% |